# Hye Ryun Kim

Source: https://onco.cc/people/kim-hye-ryun/  
OnCo record `kim-hye-ryun` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Yonsei oncologist who has led checkpoint-inhibitor and combination trials in lung and head-and-neck cancer.

## Summary

Hye Ryun Kim is Professor of Medical Oncology at Severance Hospital, Yonsei University, in Seoul, working in thoracic and head and neck oncology. She has led checkpoint-inhibitor and combination trials in lung cancer and head and neck cancer, including trials of PD-1 combinations in non-small-cell lung cancer and head and neck squamous cell carcinoma. Her work also includes immunotherapy biomarker studies that seek to identify which patients respond to immune checkpoint inhibitors. Her interests are lung cancer, head and neck cancer and immunotherapy.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Medical Oncology; thoracic and head-and-neck oncology
- Specialisms: Lung cancer; Head and neck cancer; Immunotherapy

## Sources

- Yonsei Cancer Center: https://sev.severance.healthcare
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Kim%20HR%5BAuthor%5D%20Yonsei%20lung%20cancer%20immunotherapy

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- institutions: [Severance Hospital, Yonsei University](https://onco.cc/institutions/severance/)

---
JSON: https://onco.cc/api/v1/entities/kim-hye-ryun.json